Core Viewpoint - Starcoin Group Limited (formerly known as Innovative Pharmaceutical Biotech Limited) experienced a significant stock price drop, with a decline exceeding 70% following a notification from the Hong Kong Stock Exchange regarding insufficient operational levels and asset value to support continued listing [1][2]. Group 1: Company Announcement and Stock Performance - On November 14, 2025, the company received a letter from the Stock Exchange indicating that it failed to maintain sufficient operational levels and asset value, leading to a decision to suspend trading of its shares on November 26, 2025 [2][3]. - The company had previously announced a failed placement agreement to issue up to 145 million shares at HKD 0.415 per share, as the conditions precedent were not met by September 11, 2025 [1][3]. Group 2: Financial Performance - For the fiscal year ending March 31, 2025, the company reported a revenue of HKD 2.091 million, a year-on-year decrease of 68.28%, and a net loss attributable to shareholders of HKD 346 million, compared to a profit of HKD 103 million in the previous year [5]. - The basic earnings per share for the reporting period were -HKD 0.2001, with net cash flow from operating activities at -HKD 10.555 million, a decrease of HKD 2.276 million year-on-year [5].

Core Viewpoint - The company, 拉近网娱 (08172), is facing potential delisting from the GEM market due to insufficient business operations and asset levels as per GEM listing rules [1] Summary by Relevant Sections Company Announcement - The board of the company has informed shareholders and potential investors about a review hearing scheduled for October 21, 2025, regarding the listing decision [1] - On November 3, 2025, the company received a letter from the Stock Exchange indicating that the committee believes the company has not maintained sufficient business operations and asset levels to ensure continued listing [1] Listing Rules and Procedures - According to GEM listing rules, the company has the right to submit the committee's decision for review by the GEM Listing Review Committee [1] - The company can request this review within 7 business days after the committee's decision, which is by November 12, 2025 [1] - The company is currently seeking advice from external consultants to decide whether to appeal the committee's decision [1] Trading Status - Unless the company applies for a review, its shares will be suspended from trading starting November 13, 2025, after the 7 business days following the committee's decision [1] - Until a decision is made regarding the appeal, the company's shares will continue to trade [1]

Core Viewpoint - The company, 拉近网娱 (08172), is facing potential delisting from the GEM market due to insufficient business operations and asset levels as per GEM listing rules [1] Group 1: Company Announcement - The board of the company has informed shareholders and potential investors about a review hearing scheduled for October 21, 2025, regarding the listing decision [1] - On November 3, 2025, the company received a letter from the Stock Exchange indicating that the committee believes the company has not maintained sufficient business operations and asset levels to ensure continued listing [1] - The decision to maintain the suspension of trading in the company's shares is based on GEM listing rule 9.04(3) [1] Group 2: Review Process - The company has the right to submit the committee's decision for review by the GEM Listing Review Committee according to GEM listing rule 4 [1] - The company can request this review within 7 business days after the committee's decision, specifically by November 12, 2025 [1] - The company is currently seeking advice from external consultants to decide whether to appeal the committee's decision [1] Group 3: Trading Status - Unless the company applies for a review, its shares will be suspended from trading starting November 13, 2025, after the expiration of the 7 business days [1] - Until a decision is made regarding the appeal, the company's shares will continue to trade [1]

Core Viewpoint - Far East Holdings International (00036) has received a letter from the Stock Exchange indicating that the Listing Committee has determined the company has failed to maintain sufficient operational levels and asset value to support its continued listing [1] Group 1 - The Listing Committee's decision is based on the consideration of all documents submitted by the company and the Listing Division, both written and oral [1] - The Listing Committee has decided to uphold the suspension of trading in the company's shares as per Listing Rule 6.01(3) [1] - The company is currently reviewing the Listing Committee's decision and is engaged in internal discussions regarding the possibility of requesting a review by the Listing Review Committee [1]